HomeSYRE • NASDAQ
add
Spyre Therapeutics Inc
Previous close
$27.00
Day range
$26.73 - $28.01
Year range
$10.42 - $47.97
Market cap
1.42B USD
Avg Volume
597.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.39M | 66.62% |
Net income | -69.03M | -72.11% |
Net profit margin | — | — |
Earnings per share | -1.36 | 85.44% |
EBITDA | -55.21M | -66.06% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 414.23M | 103.45% |
Total assets | 421.09M | 103.16% |
Total liabilities | 93.70M | 42.92% |
Total equity | 327.39M | — |
Shares outstanding | 51.43M | — |
Price to book | 8.08 | — |
Return on assets | -32.31% | — |
Return on capital | -39.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -69.03M | -72.11% |
Cash from operations | -29.42M | 14.96% |
Cash from investing | 42.74M | 143.78% |
Cash from financing | 12.78M | 201.99% |
Net change in cash | 26.12M | 118.04% |
Free cash flow | 16.79M | 109.23% |
About
Founded
Jan 1, 2013
Headquarters
Website
Employees
60
